PARP1 is considered a potential target for overcoming chemotherapy resistance, as it enhances the repair of DNA-damaged cells by recruiting DNA damage response proteins, such as γH2AX and BRCA1/2, which are linked to reduced survival rates in osteosarcoma patients [101]. The gene discussed is PARP1; the disease is osteosarcoma.